Keyphrases
Non-small Cell Lung Cancer (NSCLC)
100%
Patient Survival
100%
Mutation Status
100%
Post-resection
100%
Lung Cancer Brain Metastases
100%
Tumor
33%
Resection
33%
Brain Metastases
33%
EGFR mutation
33%
Prolonged Survival
33%
Tyrosine Kinase Inhibitor Therapy
33%
Clinical Treatment
16%
Primary Tumor
16%
Counseling
16%
Multivariate Analysis
16%
Demographic Characteristics
16%
Prognostic Value
16%
Karnofsky Performance Status
16%
Overall Survival
16%
Testing Data
16%
Molecular Diagnostics
16%
Smokers
16%
Clinical Factors
16%
Cox Regression
16%
Age at Surgery
16%
Stereotactic Radiosurgery
16%
Neurosurgery
16%
Academic Center
16%
Prognostic Marker
16%
Single Surgeon
16%
Systemic Therapy
16%
Tumor Diameter
16%
Predictive Variables
16%
Neurosurgical Resection
16%
ROS1
16%
Assessment Score
16%
Intracranial Disease
16%
Graded Prognostic Assessment
16%
Medicine and Dentistry
Non Small Cell Lung Cancer
100%
Biological Marker
100%
Brain Metastasis
100%
Epidermal Growth Factor Receptor
66%
Neoplasm
50%
Surgery
50%
Tyrosine-Kinase Inhibitor
33%
Disease
16%
Multivariate Analysis
16%
Surgeon
16%
Smoking
16%
Proportional Hazards Model
16%
Karnofsky Performance Status
16%
Primary Tumor
16%
Decision Making
16%
Systemic Therapy
16%
Counseling
16%
Stereotactic Radiosurgery
16%
Neurosurgery
16%
Overall Survival
16%
Demography
16%
Prognostic Assessment
16%